Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Simbol: 002603.SZ
SHZ
19.58
CNYTržna cena danes
12.0881
Razmerje P/E
1.2606
Razmerje PEG
32.71B
Kapaciteta MRK
- 0.03%
Donos DIV
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603-SZ) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 8322.47 | 2422.7 | 1050.5 | 1554 | |||||||||||||||
balance-sheet.row.short-term-investments | 2554.79 | 518.4 | 55.3 | 217 | |||||||||||||||
balance-sheet.row.net-receivables | 11259.24 | 2699.6 | 2593.1 | 2102.4 | |||||||||||||||
balance-sheet.row.inventory | 9782.92 | 2021.8 | 1672.7 | 1580.3 | |||||||||||||||
balance-sheet.row.other-current-assets | 631.46 | 110.1 | 285.8 | 222.7 | |||||||||||||||
balance-sheet.row.total-current-assets | 29996.09 | 7254.2 | 5602.1 | 5459.4 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 26574.19 | 6221.8 | 5745.5 | 4299.1 | |||||||||||||||
balance-sheet.row.goodwill | 228.47 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.intangible-assets | 3445.29 | 828 | 897.9 | 736.6 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3673.77 | 828 | 897.9 | 736.6 | |||||||||||||||
balance-sheet.row.long-term-investments | 4655.45 | 830.5 | -54.3 | -216 | |||||||||||||||
balance-sheet.row.tax-assets | 820.62 | 279.9 | 117 | 137.8 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 4451.29 | 921.8 | 596.6 | 1075.3 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 40175.32 | 9081.9 | 7302.7 | 6032.9 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 70171.42 | 16336.1 | 12904.8 | 11492.3 | |||||||||||||||
balance-sheet.row.account-payables | 10015.9 | 2060.8 | 1621.2 | 1188.4 | |||||||||||||||
balance-sheet.row.short-term-debt | 3422.6 | 656.3 | 513.9 | 270.2 | |||||||||||||||
balance-sheet.row.tax-payables | 1098.62 | 474 | 123.2 | 133.9 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 1455.8 | 215.1 | 513 | 10.5 | |||||||||||||||
Deferred Revenue Non Current | 1400.88 | 335 | 357.8 | 328.1 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 263.2 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 1781.83 | 1027.3 | 216.3 | 28.3 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 3119.87 | 555.7 | 872.2 | 330.1 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 54.95 | 15 | 12.5 | 10.5 | |||||||||||||||
balance-sheet.row.total-liab | 23563.79 | 5405.8 | 3832.7 | 2569 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 6682.82 | 1670.7 | 1670.7 | 1203.7 | |||||||||||||||
balance-sheet.row.retained-earnings | 26853.23 | 5989.2 | 4306.2 | 4324.4 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 8524.94 | 989 | 808.9 | 640.9 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 4566.63 | 2283.3 | 2283.3 | 2750.3 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 46627.62 | 10932.2 | 9069.1 | 8919.3 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 70171.42 | 16336.1 | 12904.8 | 11492.3 | |||||||||||||||
balance-sheet.row.minority-interest | -19.99 | -1.9 | 3 | 4.1 | |||||||||||||||
balance-sheet.row.total-equity | 46607.63 | 10930.3 | 9072.2 | 8923.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 70171.42 | - | - | - | |||||||||||||||
Total Investments | 7210.24 | 1348.9 | 1 | 1 | |||||||||||||||
balance-sheet.row.total-debt | 4878.39 | 871.4 | 1026.9 | 270.2 | |||||||||||||||
balance-sheet.row.net-debt | -889.29 | -1032.8 | 31.6 | -1066.8 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 2706.16 | 2356.8 | 1341.6 | 1214.9 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 121.87 | 451.5 | 362.9 | 268.2 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -158.7 | 20.1 | -67.7 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 158.7 | -20.1 | 67.7 | |||||||||||||||
cash-flows.row.change-in-working-capital | -1179.67 | 547.8 | -1309.7 | 24.8 | |||||||||||||||
cash-flows.row.account-receivables | -831.66 | -831.7 | -1280.3 | -668.7 | |||||||||||||||
cash-flows.row.inventory | -348.01 | -348 | -104.7 | -364.9 | |||||||||||||||
cash-flows.row.account-payables | 22.82 | 1886.2 | 55.1 | 1126.1 | |||||||||||||||
cash-flows.row.other-working-capital | -22.82 | -158.7 | 20.1 | -67.7 | |||||||||||||||
cash-flows.row.other-non-cash-items | 245.91 | 131.6 | 133.9 | 78.3 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1894.27 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -246.9 | -214 | -673.6 | -1144.8 | |||||||||||||||
cash-flows.row.acquisitions-net | -628.54 | 0.4 | 2.4 | 1145.1 | |||||||||||||||
cash-flows.row.purchases-of-investments | -5902.36 | -3461.9 | -451 | -2853.3 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 4047.54 | 1680.7 | 616.6 | 2957.6 | |||||||||||||||
cash-flows.row.other-investing-activites | 0.36 | 0 | -1.2 | -1144.8 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -2729.91 | -1994.8 | -506.8 | -1040.2 | |||||||||||||||
cash-flows.row.debt-repayment | -1250 | -2200 | -1469.9 | -270 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | -413.64 | -282.7 | -1220.1 | -244.1 | |||||||||||||||
cash-flows.row.other-financing-activites | 1321.67 | 1845.7 | 2387.9 | 490.8 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -341.96 | -637 | -302.1 | -23.3 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.28 | 1.2 | -0.5 | -2 | |||||||||||||||
cash-flows.row.net-change-in-cash | -663.1 | 857.2 | -280.7 | 520.8 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 5395.81 | 1810.7 | 953.5 | 1234.2 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 6058.9 | 953.5 | 1234.2 | 713.4 | |||||||||||||||
cash-flows.row.operating-cash-flow | 1894.27 | 3487.7 | 528.7 | 1586.2 | |||||||||||||||
cash-flows.row.capital-expenditure | -246.9 | -214 | -673.6 | -1144.8 | |||||||||||||||
cash-flows.row.free-cash-flow | 1647.37 | 3273.8 | -144.9 | 441.4 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 13161.66 | 12532.8 | 10116.8 | 8782.5 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 4867.04 | 4540.6 | 3681 | 3118.4 | |||||||||||||||
income-statement-row.row.gross-profit | 8294.62 | 7992.3 | 6435.8 | 5664.1 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 1074.04 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 235.76 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3177.48 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 505.39 | 576.9 | 366.6 | 323 | |||||||||||||||
income-statement-row.row.operating-expenses | 4982.24 | 5025.8 | 4758.7 | 4179.2 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 9849.29 | 9566.4 | 8439.7 | 7297.6 | |||||||||||||||
income-statement-row.row.interest-income | 14.34 | 12.9 | 20.4 | 7 | |||||||||||||||
income-statement-row.row.interest-expense | 36.75 | 33.8 | 34 | 3.8 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3177.48 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | -20.99 | -48.9 | -15.4 | -15.6 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 505.39 | 576.9 | 366.6 | 323 | |||||||||||||||
income-statement-row.row.total-operating-expenses | -20.99 | -48.9 | -15.4 | -15.6 | |||||||||||||||
income-statement-row.row.interest-expense | 36.75 | 33.8 | 34 | 3.8 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 100.71 | 546.1 | 448.6 | 329.5 | |||||||||||||||
income-statement-row.row.ebitda-caps | 3303.32 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 3202.61 | 2829.6 | 1569.1 | 1438 | |||||||||||||||
income-statement-row.row.income-before-tax | 3181.62 | 2780.6 | 1553.7 | 1422.5 | |||||||||||||||
income-statement-row.row.income-tax-expense | 482.98 | 423.8 | 212.1 | 207.5 | |||||||||||||||
income-statement-row.row.net-income | 2706.16 | 2361.8 | 1343.9 | 1218.7 |
Pogosto zastavljeno vprašanje
Kaj je Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) skupna sredstva?
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) skupna sredstva so 16336112689.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 4639721722.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.630.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 0.986.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.206.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.243.
Kaj je Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 2361804714.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 871449540.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 5025828583.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 1072618858.000.